Hepatitis C Therapy: Serendipitous Successes

摘要: of IFN and RBV, two years earlier. He was Child-Pugh class A had no evidence liver decompensation on examination. His baseline HCV RNA 1.50x10 IU/ mL. started treatment with IFN, RBV telaprevir. experienced side effects therapy including anorectal burning, constipation, fatigue, anemia requiring erythropoetin injections. also achieved rapid virologic response at one month into therapy. Three months therapy, the patient developed an abscess in right axilla, which required surgical drainage indwelling drain. Antiviral terminated that time. 64 weeks after termination treatment, remains SVR complaints.